Figure 2.

Responses of hematological cell lines to kinase inhibitors. AML cells were exposed to 1 μM PI-103, 10 μM MEK-i, or 1 μM JAK-i for 72 h and viability measured by MTS and expressed as percentage to DMSO (control) treated cells. Cell lines were then ranked according to their responses to the inhibitors. Values are mean ± SD (n = 4).